Bacterial delivery of nuclear proteins into pluripotent and differentiated cells

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Bichsel, Candace ^a   Neeld, Dennis K ^a   Hamazaki, Takashi ^a   Wu, Donghai ^b   Chang, Lung Ji ^a   Yang, Lijun ^a   Terada, Naohiro ^a   Jin, Shouguang ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CRE RECOMBINASE; NUCLEAR PROTEIN; PSEUDOMONAS EXOTOXIN; BACTERIAL TOXIN; EXOENZYME S; INTEGRASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; BACTERIUM MUTANT; CELL DIFFERENTIATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOTOXICITY; DNA RECOMBINATION; EMBRYONIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PLASMID; PLURIPOTENT STEM CELL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SARCOMA CELL; TYPE III SECRETION SYSTEM; ANIMAL; BACTERIAL SECRETION SYSTEM; BACTERIUM; CELL CULTURE; CHEMISTRY; DRUG DELIVERY SYSTEM; GENETIC RECOMBINATION; METABOLISM; METHODOLOGY; NUCLEAR REPROGRAMMING; TUMOR CELL LINE;

BACTERIA (MICROORGANISMS); EUKARYOTA; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA;

ADP RIBOSE TRANSFERASES; ANIMALS; BACTERIA; BACTERIAL SECRETION SYSTEMS; BACTERIAL TOXINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL NUCLEUS; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; HUMANS; INTEGRASES; MICE; NUCLEAR LOCALIZATION SIGNALS; NUCLEAR PROTEINS; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELLS; PSEUDOMONAS AERUGINOSA; RECOMBINATION, GENETIC; TRANSCRIPTION FACTORS;

EID: 79551563238     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016465     Document Type: Article

References (35)

1. Cornelis GR (2006) The type III secretion injectisome. Nat Rev Micro 4: 811-825.
2. Galan JE, Wolf-Watz H (2006) Protein delivery into eukaryotic cells by type III secretion machines. Nature 444: 567-573.
3. Hauser AR (2009) The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Micro 7: 654-665.
4. Tampakaki A, Fadouloglou V, Gazi A, Panopoulos N, Kokkinidis M (2004) Conserved features of type III secretion. Cell Micro 6: 805-816.
5. Epaulard O, Toussaint B, Quenee L, Derouazi M, Bosco N, et al. (2006) Antitumor immunotherapy via antigen delivery from a live attenuated genetically engineered Pseudomonas aeruginosa type III secretion system-based vector. Mol Ther 14: 656-661.
6. Polack B, Vergnaud S, Paclet MH, Lamotte D, Toussaint B, et al. (2000) Protein delivery by Pseudomonas type III secretion system: ex vivo complementation of p67phox-deficient chronic granulomatous disease. Biochem Biophy Res Comm 275: 854-858.
7. Russmann H, Shams H, Poblete F, Fu Y, Galan JE, et al. (1998) Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science 281: 565-568.
8. Dasgupta N, Ashare A, Hunninghake GW, Yahr TL (2006) Transcriptional induction of the Pseudomonas aeruginosa type III secretion system by low Ca2+ and host cell contact proceeds through two distinct signaling pathways. Infect Immun 74: 3334-3341.
9. Kim J, Ahn K, Min S, Jia J, Ha U, et al. (2005) Factors triggering type III secretion in Pseudomonas aeruginosa. Microbiol 151: 3575-3587.
10. Barbieri JT, Sun J (2005) Pseudomonas aeruginosa ExoS and ExoT. Rev Physiol Biochem Pharmacol 152: 79-92.
11. Yahr TL, Vallis AJ, Hancock MK, Barbieri JT, Frank DW (1998) ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. Proc Nat Acad Sci USA 95: 13899-13904.
12. Lee VT, Smith RS, Tummler B, Lory S (2005) Activities of Pseudomonas aeruginosa effectors secreted by the type III secretion system in vitro and during Infection. Infect Immun 73: 1695-1705.
13. Rabin SD, Hauser AR (2005) Functional regions of the Pseudomonas aeruginosa cytotoxin ExoU. Infect Immun 73: 573-582.
14. Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
15. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
16. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al. (2007) Induced pluripotent stem cell lines derived from human somatic Cells. Science 318: 1917-1920.
17. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, et al. (2009) Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458: 771-775.
18. Chang CW, Lai YS, Pawlik KM, Liu K, Sun CW, et al. (2009) Polycistronic lentiviral vector for ''hit and run'' reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Stem Cells 27: 1042-1049.
19. Sauer B, Henderson N (1988) Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Pro Nat Acad Sci USA 85: 5166-5170.
20. Nagy A (2000) Cre recombinase: The universal reagent for genome tailoring. Genesis 26: 99-109.
21. Sundin C, Wolfgang MC, Lory S, Forsberg A, Frithz-Lindsten E (2002) Type IV pili are not specifically required for contact dependent translocation of exoenzymes by Pseudomonas aeruginosa. Microb Pathog 33: 265-277.
22. Srinivas S, Watanabe T, Lin CS, William C, Tanabe Y, et al. (2001) Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Develop Biol 1: 4.
23. Yu J, Rossi R, Hale C, Goulding D, Dougan G (2009) Interaction of enteric bacterial pathogens with murine embryonic stem cells. Infect Immun 77: 585-597.
24. Zhou H, Wu S, Joo JY, Zhu S, Han DW, et al. (2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4: 381-384.
25. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, et al. (2009) Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4: 472-476.
26. Oka M, Chang LJ, Costantini F, Terada N (2006) Lentiviral vector-mediated gene transfer in embryonic stem cells. Methods Mol Biol 329: 273-281.
27. Marx C (2008) Development of a broad-host-range sacB-based vector for unmarked allelic exchange. BMC Res Notes 1: 1-1.
28. Zaiss AK, Son S, Chang LJ (2002) RNA 39 readthrough of oncoretrovirus and lentivirus: Implications for vector safety and efficacy. J Virol 76: 7209-7219.
29. Hamazaki T, Kehoe SM, Nakano T, Terada N (2006) The Grb2/Mek pathway represses Nanog in murine embryonic stem cells. Mol Cell Biol 26: 7539-49.
30. Holloway BW, Krishnapillai V, Morgan AF (1979) Chromosomal genetics of Pseudomonas. Microbiol Rev 43: 73-102.
31. Simon R, Priefer U, Puhler A (1983) A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria. Nat Biotech 1: 784-791.
32. Hanahan D (1983) Studies on transformation of Escherichia coli with plasmids. J Mol Biol 166: 557-80.
33. West SE, Schweizer HP, Dall C, Sample AK, Runyen-Janecky LJ (1994) Construction of improved Escherichia-Pseudomonas shuttle vectors derived from pUC18/19 and sequence of the region required for their replication in Pseudomonas aeruginosa. Gene 148: 81-86.
34. Ha U, Jin S (2001) Growth phase-dependent invasion of Pseudomonas aeruginosa and its survival within HeLa cells. Infect Immun 69: 4398-4406.
35. Hoang TT, Karkhoff-Schweizer RR, Kutchma AJ, Schweizer HP (1998) A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212: 77-86.